As of May 2024 Palatin Technologies has a market cap of $33.68 Million. This makes Palatin Technologies the world's 7887th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $33.68 M | -38.4% |
2023 | $54.67 M | 106.27% |
2022 | $26.5 M | -77.6% |
2021 | $0.11 B | -23.87% |
2020 | $0.15 B | -13.28% |
2019 | $0.17 B | 24.62% |
2018 | $0.14 B | -12% |
2017 | $0.16 B | 142.55% |
2016 | $67.39 M | 49.19% |
2015 | $45.17 M | 48.96% |
2014 | $30.32 M | 5.41% |
2013 | $28.76 M | 23.12% |
2012 | $23.36 M | 66.58% |
2011 | $14.02 M | -12.35% |
2010 | $16 M | -54.99% |
2009 | $35.55 M | 356.31% |
2008 | $7.79 M | -54.28% |
2007 | $17.04 M | -88.26% |
2006 | $0.14 B | -24.6% |
2005 | $0.19 B | 34.01% |
2004 | $0.14 B | 26.58% |
2003 | $0.11 B | 102.25% |
2002 | $56.13 M | -17.02% |
2001 | $67.64 M |
On May 14th, 2024 the market cap of Palatin Technologies was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $367.42 B | 1,090,833.25% | ๐บ๐ธ USA |
AstraZeneca AZN | $239.95 B | 712,360.92% | ๐ฌ๐ง UK |
Neurocrine Biosciences
NBIX | $14.29 B | 42,329.91% | ๐บ๐ธ USA |
MediciNova MNOV | $75.05 M | 122.84% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $1.54 B | 4,474.64% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | $2.97 B | 8,741.12% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | $1.38 B | 4,014.26% | ๐บ๐ธ USA |
GlycoMimetics
GLYC | $17.4 M | -48.32% | ๐บ๐ธ USA |
Ardelyx ARDX | $1.89 B | 5,514.43% | ๐บ๐ธ USA |